A Closer Look at 7 Analyst Recommendations For Catalyst Pharmaceuticals
A Closer Look at 7 Analyst Recommendations For Catalyst Pharmaceuticals
分析師對catalyst pharmaceuticals的7個推薦做出更深入的研究
Catalyst Pharmaceuticals (NASDAQ:CPRX) has been analyzed by 7 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
在過去的三個月中，Catalyst Pharmaceuticals (NASDAQ:CPRX) 已經被7位分析師進行了分析，展示出了從看好到看淡的不同觀點。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
以下表格總結了分析師們最近的評級，揭示了過去30天內情緒的變化並將其與前幾個月進行了比較。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $28.43, along with a high estimate of $34.00 and a low estimate of $23.00. Marking an increase of 7.98%, the current average surpasses the previous average price target of $26.33.
更深入的洞察顯示，分析師們建立了爲期12個月的價格目標，顯示平均目標爲28.43美元，高估爲34.00美元，低估爲23.00美元。當前平均值超過了之前的平均目標價格26.33美元，增加了7.98%。
Analyzing Analyst Ratings: A Detailed Breakdown
分析分析師評級：詳細剖析
The perception of Catalyst Pharmaceuticals by financial...
通過最近的分析...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。